| Bioactivity | Tyrosinase-IN-35 (compound 6g) is a human tyrosinase inhibitor (IC50: 2.09 μM), which is more potent than Kojic Acid (HY-W050154) (IC50: 16.38 μM). Tyrosinase-IN-35 can reduce the melanin content of melanoma B16F10 cells in vitro at doses of 4 μM and 8 μM[1]. |
| Target | IC50: 2.09 μM (Tyrosinase) |
| CAS | 1613467-47-2 |
| Formula | C17H15N5OS |
| Molar Mass | 337.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kinetic studies, molecular docking, and antioxidant activity of novel 1,3-diphenyl pyrazole-thiosemicarbazone with anti-tyrosinase and anti-melanogenesis properties |
Tyrosinase-IN-35
CAS: 1613467-47-2 F: C17H15N5OS W: 337.40
Tyrosinase-IN-35 (compound 6g) is a human tyrosinase inhibitor (IC50: 2.09 μM), which is more potent than Kojic Acid (H
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.